Benharkate M, Plassard G, Legeai J, Worcel M
Arzneimittelforschung. 1986 Dec;36(12):1761-7.
The antiarrhythmic activity of 4-(2-benzofuranyl)-2-(dimethylamino)-1-pyrroline (prifuroline) has been evaluated in rats, guinea-pigs and dogs. Prifuroline dose-dependently antagonizes the arrhythmogenic action of aconitine in rats, when administered either intravenously (5, 10 or 20 mg/kg) or intraduodenally (10, 20 or 50 mg/kg); it exhibits effectiveness by the digestive route at doses only twice as greater as the active i.v. doses: its intravenous anti-aconitine activity is comparable to that of disopyramide, and superior to that of quinidine; lidocaine is inactive in this test. Prifuroline also diminishes ventricular susceptibility to electrical stimulation in open-chest rats; its effect is comparable to that of disopyramide and amiodarone at the same dose levels; quinidine and lidocaine are less effective. Only prifuroline and propranolol were able to antagonize ouabain toxicity in guinea-pigs, quinidine showing only borderline activity, and disopyramide, lidocaine and verapamil being ineffective. In a model of arrhythmias induced by anoxic stress in rats, all the tested compounds were found active, with prifuroline and disopyramide providing complete protection at high dose levels. The arrhythmias induced in dogs by coronary artery ligation were markedly antagonized by prifuroline after doses of 5 and 10 mg/kg i.v. or 30 mg/kg intraduodenally; the duration of its antiarrhythmic activity in this model of arrhythmias in conscious dogs was much longer after intraduodenal than after i.v. administration. Prifuroline was also able to restore sinus rhythm in guinea-pigs after intracardiac conduction blockade with acetylcholine, although being devoid of anticholinergic activity. It also diminishes the maximal frequency of guinea-pig atria electrically stimulated in viro (EC25 = 5 X 10(-6) g/ml).(ABSTRACT TRUNCATED AT 250 WORDS)
已在大鼠、豚鼠和犬中评估了4-(2-苯并呋喃基)-2-(二甲基氨基)-1-吡咯啉(普呋罗林)的抗心律失常活性。当静脉注射(5、10或20mg/kg)或十二指肠内给药(10、20或50mg/kg)时,普呋罗林在大鼠中剂量依赖性地拮抗乌头碱的致心律失常作用;它通过消化道给药时,有效剂量仅为静脉注射有效剂量的两倍:其静脉注射抗乌头碱活性与丙吡胺相当,且优于奎尼丁;利多卡因在此试验中无活性。普呋罗林还可降低开胸大鼠心室对电刺激的易感性;在相同剂量水平下,其效果与丙吡胺和胺碘酮相当;奎尼丁和利多卡因效果较差。只有普呋罗林和普萘洛尔能够拮抗豚鼠中哇巴因的毒性,奎尼丁仅表现出临界活性,而丙吡胺、利多卡因和维拉帕米无效。在大鼠缺氧应激诱导的心律失常模型中,所有测试化合物均有活性,普呋罗林和丙吡胺在高剂量水平时提供完全保护。静脉注射5和10mg/kg或十二指肠内注射30mg/kg剂量的普呋罗林后,可明显拮抗犬冠状动脉结扎诱导的心律失常;在清醒犬的这种心律失常模型中,其抗心律失常活性的持续时间十二指肠内给药比静脉注射长得多。在用乙酰胆碱进行心内传导阻滞的豚鼠中,普呋罗林也能够恢复窦性心律,尽管它没有抗胆碱能活性。它还可降低体外电刺激的豚鼠心房的最大频率(EC25 = 5×10(-6) g/ml)。(摘要截短于250字)